))
Nutromics – Better healthcare by way of continuous molecular monitoring
Manage episode 323861910 series 3007793
Sisällön tarjoaa Artesian. Artesian tai sen podcast-alustan kumppani lataa ja toimittaa kaiken podcast-sisällön, mukaan lukien jaksot, grafiikat ja podcast-kuvaukset. Jos uskot jonkun käyttävän tekijänoikeudella suojattua teostasi ilman lupaasi, voit seurata tässä https://fi.player.fm/legal kuvattua prosessia.
We talk to Australian MedTech company Nutromics’ Co-founders and Co-CEOs, Hitesh Mehta and Peter Vranes.
Nutromics is aiming to transform healthcare by bringing continuous molecular monitoring (CMM) to market. We discuss our existing healthcare system’s reliance on blood draws for analysis, as well as the new CMM biosensors being developed by Nutromics that provide real-time molecular data to clinicians and patients. Find out how these small, wearable patches can improve the patient experience and even save lives by speeding up clinical analysis and assisting with pre-symptomatic diagnosis.
https://www.nutromics.com.au/
This is episode 11 of the ArteHouse Innovation Series with Ali & Tim.
23 jaksoa
Jaa
